Skip to main content
. 2021 Oct 14;12:729851. doi: 10.3389/fimmu.2021.729851

Figure 2.

Figure 2

NPC2- and IGF2-tagged bsAbs neutralize VSV-EBOV in multiple cell types. Neutralization curves of bsAbs and parental mAbs against rVSV-EBOV GP in (A-D) human U2OS osteosarcoma cells or (E-H) human THP-1 cells differentiated into macrophage-like cells. Infection was measured by automated counting of eGFP+ cells and normalized to infection in absence of antibody. Means ± SD are shown for 4–8 replicates from 2–4 independent experiments.